Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High performance gene delivery polymeric vector: nano-structured cationic star polymers (star vectors).

Yasuhide Nakayama1, Takeshi Masuda, Makoto Nagaishi

  • 1Department of Bioengineering, National Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan. nakayama@ri.ncvc.go.jp

Current Drug Delivery
|November 25, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 Trial.

Journal of atherosclerosis and thrombosis·2026
Same author

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Atherosclerosis·2026
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journal·2026
Same author

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

European journal of preventive cardiology·2026
Same author

A Phase 1 Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Zerlasiran in Japanese Participants.

Journal of atherosclerosis and thrombosis·2026
Same author

Myocardial infarction due to nonbacterial thrombotic endocarditis in a patient with advanced bladder cancer.

Cardiovascular intervention and therapeutics·2026

Novel star polymers were developed as non-viral gene delivery vectors. Increased branching of these cationic polymers enhanced gene expression in cells with minimal toxicity, demonstrating controlled gene transfer activity.

Area of Science:

  • Polymer Chemistry
  • Biotechnology
  • Nanotechnology

Background:

  • Non-viral vectors are crucial for safe gene delivery.
  • Cationic polymers are explored for their ability to complex with DNA.
  • Hyperbranched structures offer unique properties for vector design.

Purpose of the Study:

  • To design and synthesize novel nano-structured hyperbranched cationic star polymers as gene delivery vectors.
  • To investigate the effect of polymer branching on gene delivery efficiency and cytotoxicity.
  • To establish structure-activity relationships for cationic star polymers in gene transfer.

Main Methods:

  • Synthesis of linear and branched cationic polymers using photo-living-radical polymerization.
  • Formation of polyplexes between polymers and plasmid DNA (pDNA).

Related Experiment Videos

  • Characterization of polyplex size and zeta-potential.
  • Evaluation of gene expression and cytotoxicity in COS-1 cells.

    • Main Results:

    • Star polymers with varying branching (3, 4, 6) were successfully synthesized.
    • Polyplexes formed with pDNA exhibited particle sizes around 150-250 nm and positive zeta-potential.
    • Gene expression increased significantly with higher polymer branching (2-10 fold increase compared to linear).
    • Cytotoxicity was minimal across different polymer architectures.

    Conclusions:

    • Nano-structured hyperbranched cationic star polymers are effective non-viral gene delivery vectors.
    • Polymer branching is a key factor in controlling gene transfer efficiency.
    • These star vectors offer a promising platform for targeted and efficient gene therapy applications.